FBRX

Forte Biosciences, Inc.

Healthcare · Biotechnology

$175.59 sample

+1.38 (+0.79%) 1D

Market cap

$246.9B

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$175.59 +14.36% 3M daily closessample

175.59151.97

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider buy: EVP, Operations
Oct 06INSInsider sell: Chief Executive Officer
Sep 30INSInsider sell: Chief Financial Officer
Sep 24INSInsider sell: 10% owner
Sep 15INSInsider sell: Chief Executive Officer
Sep 07INSInsider sell: Chief Financial Officer
Aug 27INSInsider buy: 10% owner
Aug 18INSInsider sell: Chief Financial Officer

Sign up to see the real FBRX record →

Company facts

SEC EDGAR registration

Name: Forte Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -31sample, -100 to +100
Reporting currency: USD

Who is positioning in FBRX

sample

Insiders: 22 insider transactions over 90 days, net selling, $563.3M
Congress: 2 members traded over 90 days
Institutions · 13F: 29 funds hold $4.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$13.8B +19.3% y/y

Q4 2024Q3 2026

Inventory$8.2B +11.3% y/y

Q4 2024Q3 2026

Accounts receivable$6.1B +9.9% y/y

Q4 2024Q3 2026

Total debt$16.3B +18.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $71.9B +11.4% 3M
Sample peer B: $172.5B -1.8% 3M
Sample peer C: $45.0B -7.3% 3M
Sample peer D: $77.7B -11.5% 3M
Sample peer E: $209.5B +10.3% 3M